GDUFA Research Outcomes
Drug-Device Combo Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to considerations impacting the device constituent of generic drug-device combination products.
-
An FDA Perspective on Best Practices for Comparative Analyses: Challenges & Opportunities
Feibus, Katherine; Fine, Andrew; Flint, Jason
-
Drug-Device Combination Products
Feibus, Karen
-
Considerations for Pre-ANDA Meeting Requests and Case Scenario Setup: Device Constituent of Hypothetical BREATHEATOL Drug Product
Conti, Denise
-
Introduction to Session 4: Device Considerations for Complex Drug-Device Combination Products
Conti, Denise
-
Device Considerations for Pre-ANDA Meeting Requests for Complex Drug-Device Combination Products
Conti, Denise
-
Overview of Complex Generic Inhalation, Nasal and Auto-Injector Drug-Device Combination Products
Conti, Denise
-
Emerging Technologies for Bioequivalence of Generic Complex Drug-Device Combination Products
Conti, Denise
-
Determining “Other Design Differences” and Ways to Support Generic Substitutability
Conrad, Megan; Privitera, Mary Beth
-
Pre-ANDA Opportunities for Generic Drug-Device Combination Product Development
Clerman, Andrew
-
Quality Considerations for Injectable Drug-Device Combination Products in Abbreviated New Drug Applications (ANDAs)
Chang, Richard